Clinical trials all over the world are showing positive results when treating COVID-19 patients suffering from ARDS with MSCs.
The worldwide race to develop effective therapies for complications from COVID-19 infection are ongoing. Patients with particularly severe responses are often diagnosed with acute respiratory distress syndrome (ARDS).